[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100648721":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":24,"centralContacts":28,"locations":34,"responsibleParty":50,"collaborators":53,"id":60,"slug":61,"hasResults":62,"nctId":63,"briefTitle":64,"officialTitle":65,"acronym":66,"eligibilityCriteria":67,"healthyVolunteers":62,"sex":68,"minAge":69,"maxAge":18,"enrollmentInfo":70,"targetDuration":18,"studyType":73,"phases":74,"briefSummary":76,"conditions":77,"keywords":79,"overallStatus":84,"whyStopped":18,"lastUpdateSubmitDate":85,"lastUpdatePostDateStruct":86,"startDateStruct":89,"completionDateStruct":91,"leadSponsor":93,"locationsCount":94},{"fullName":5,"class":6},"University of Manitoba","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Intervention Arm","EXPERIMENTAL","Individuals randomized to the intervention group will receive a letter from MCHP. A follow-up reminder letter will be sent at 3 months in individuals that do not respond to the initial invitation. Individuals who respond to the letter by contacting the study team will be scheduled for an initial clinic appointment with a Clinical Assistant\u002FNephrologist, and will begin receiving routine clinical care thereafter, as per local clinical guidelines.",[13],"Other: Letter to participants",{"label":15,"type":16,"description":17,"interventionNames":18},"Control Arm","NO_INTERVENTION","Individuals randomized to the control group will continue receiving usual care without any intervention from the study team. Their outcomes will be ascertained using de-identified administrative data. If the trial is successful, indivdiuals in the control group will be contacted for follow-up with a nephrologist in the same manner (i.e. through a mailout letter) as the intervention group was.",null,[20],{"type":6,"name":21,"description":22,"armGroupLabels":23,"otherNames":18},"Letter to participants","Individuals randomized to the intervention group will received a direct mailing consisting of:\n\n1. A letter explaining the purpose of the study and the benefits of screening for CKD, with contact information for the study team at Seven Oaks General Hospital \u002F Chronic Disease Innovation Centre, who they may contact to receive further information and to book a follow-up appointment with a Clinical Assistant\u002FNephrologist\n2. A brief fact sheet on CKD A follow-up reminder letter will be sent at 3 months in individuals that do not respond to the initial invitation.",[9],[25],{"name":26,"affiliation":5,"role":27},"Navdeep Tangri, MD, PhD","PRINCIPAL_INVESTIGATOR",[29],{"name":30,"role":31,"phone":32,"phoneExt":18,"email":33},"Oksana Harasemiw, MSc","CONTACT","204-632-3541","oharasemiw@sogh.mb.ca",[35],{"facility":5,"status":18,"city":36,"state":37,"zip":38,"country":39,"countryCode":40,"cosmosGeoPoint":41,"geoPoint":46,"contacts":47},"Winnipeg","Manitoba","R3T 2N2","Canada","CA",{"type":42,"coordinates":43},"Point",[44,45],-97.14704,49.8844,{"lat":45,"lon":44},[48],{"name":30,"role":31,"phone":49,"phoneExt":18,"email":33},"1-204-632-3541",{"type":27,"investigatorFullName":51,"investigatorTitle":52,"investigatorAffiliation":5,"oldNameTitle":18,"oldOrganization":18},"Navdeep Tangri","Professor of Medicine",[54,57],{"name":55,"class":56},"Can-SOLVE CKD Network","UNKNOWN",{"name":58,"class":59},"Seven Oaks Hospital Chronic Disease Innovation Centre","NETWORK","100648721","designing-and-implementing-a-safety-net-surveillance-program-for-high-risk-ckd-100648721",false,"NCT07724288","Designing and Implementing a Safety Net Surveillance Program for High Risk CKD","Designing and Implementing a Safety Net Surveillance Program for High Risk CKD (CKD Safety Net)","CKD Safety-Net","Inclusion Criteria:\n\n* Age \\> 18 years old\n* Resident of Manitoba \u002F has Manitoba Health coverage\n* Either:\n* 2 eGFR \\\u003C15 mL\u002Fmin\u002F1.73m2 tests within a 2-year timeframe or\n* A greater than 10% 2-year kidney failure risk (at 2 separate timepoints within a 2-year timeframe) - using the 4-variable or 3-variable 2-year Kidney Failure Risk Equation (KFRE)\n\nExclusion Criteria:\n\n* A previous billing claim from a nephrologist\n* Receiving palliative care within 3 months of randomization\n* Previous history of dialysis and\u002For kidney transplantation","ALL","18 Years",{"count":71,"type":72},972,"ESTIMATED","INTERVENTIONAL",[75],"NA","The objective of this initiative is to develop and evaluate a risk-based, provincial public health screening program for chronic kidney disease (CKD) that provides proactive care for adults at high-risk of kidney failure who have not previously been referred to a nephrologist, through risk stratification, triage, education, and follow-up.\n\nOverall, we aim to demonstrate that an integrated risk-based provincial public health screening program for CKD is feasible, and improves identification of high-risk individuals, subsequently creating a model of care that can be adopted by other jurisdictions.",[78],"Chronic Kidney Diseases",[80,81,82,83],"Chronic Kidney Disease","Kidney Diseases","Access to care","Secondary Prevention","NOT_YET_RECRUITING","2026-08-12",{"date":87,"type":88},"2026-08-17","ACTUAL",{"date":90,"type":72},"2026-08",{"date":92,"type":72},"2028-03",{"name":5,"class":6},1]